{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig33ga2jdsunnfopn2v6ol5w2bnhoukqb5v64rwxasgfo5eu2uub4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgqr3co3cot2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig7b6hyvnjmrlgri554ixclhrc3amoqb6jqmbrlbr2m23httfkwjy"
    },
    "mimeType": "image/jpeg",
    "size": 179117
  },
  "path": "/2026/03/10/fda-says-leucovorin-evidence-lacking-for-autism/?utm_campaign=rss",
  "publishedAt": "2026-03-10T16:30:01.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Health",
    "Pharma",
    "Politics",
    "autism",
    "FDA",
    "HHS",
    "Pharmaceuticals",
    "politics"
  ],
  "textContent": "The FDA approves leucovorin for a rare brain disorder while retreating from top officials’ earlier insistence that it could benefit many children with autism.",
  "title": "Leucovorin lacks evidence to use as autism treatment, FDA says",
  "updatedAt": "2026-03-10T16:58:02.000Z"
}